Detalhe da pesquisa
1.
Immune checkpoint molecules in neuroblastoma: A clinical perspective.
Semin Cancer Biol
; 86(Pt 2): 247-258, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35787940
2.
The emerging role of non-coding RNAs in the epigenetic regulation of pediatric cancers.
Semin Cancer Biol
; 83: 227-241, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33910063
3.
Multifarious Functions of Butyrylcholinesterase in Neuroblastoma: Impact of BCHE Deletion on the Neuroblastoma Growth In Vitro and In Vivo.
J Pediatr Hematol Oncol
; 44(6): 293-304, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34486544
4.
Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma.
BMC Cancer
; 21(1): 1061, 2021 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34565342
5.
Histiocytic Neoplasms, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(11): 1277-1303, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34781268
6.
Pediatric Hodgkin Lymphoma, Version 3.2021.
J Natl Compr Canc Netw
; 19(6): 733-754, 2021 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34214968
7.
Preliminary preclinical study of Chol-DsiRNA polyplexes formed with PLL[30]-PEG[5K] for the RNAi-based therapy of breast cancer.
Nanomedicine
; 33: 102363, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33545405
8.
Radiolabeled (R)-(-)-5-iodo-3'-O-[2-(ε-guanidinohexanoyl)-2-phenylacetyl]-2'-deoxyuridine: A new theranostic for neuroblastoma.
J Labelled Comp Radiopharm
; 2020 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32150284
9.
In vitro and in vivo evaluation of radiolabeled methyl N-[5-(3'-halobenzoyl)-1H-benzimidazol-2-yl]carbamate for cancer radiotherapy.
Drug Dev Res
; 81(1): 62-69, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31593323
10.
PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective.
Semin Cancer Biol
; 52(Pt 2): 53-65, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29196189
11.
Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma.
BMC Cancer
; 19(1): 1056, 2019 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31694585
12.
Effects of novel pyrrolomycin MP1 in MYCN amplified chemoresistant neuroblastoma cell lines alone and combined with temsirolimus.
BMC Cancer
; 19(1): 837, 2019 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31455317
13.
Suppression of STAT3 NH2 -terminal domain chemosensitizes medulloblastoma cells by activation of protein inhibitor of activated STAT3 via de-repression by microRNA-21.
Mol Carcinog
; 57(4): 536-548, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29280516
14.
Butyrylcholinesterase as a Blood Biomarker in Neuroblastoma.
J Pediatr Hematol Oncol
; 39(4): 272-281, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28375942
15.
Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513.
BMC Cancer
; 16(1): 867, 2016 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27821095
16.
Cytosine arabinoside and mitoxantrone followed by second allogeneic transplant for the treatment of children with refractory juvenile myelomonocytic leukemia.
J Pediatr Hematol Oncol
; 36(6): 491-4, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24322499
17.
The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy.
Mol Ther Oncol
; 32(2): 200785, 2024 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38595981
18.
SAP30, an oncogenic driver of progression, poor survival, and drug resistance in neuroblastoma.
Mol Ther Nucleic Acids
; 35(2): 101543, 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38817681
19.
Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified Medulloblastoma.
J Exp Clin Cancer Res
; 43(1): 18, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38200580
20.
Valproic acid reduces the tolerability of temsirolimus in children and adolescents with solid tumors.
Anticancer Drugs
; 24(4): 415-21, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23328074